A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101 Baldwin, R. Michael , Owzar, Kouros , Zembutsu, Hitoshi ... - - Clin. Cancer Res. - 2012 Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101
Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101 Barginear, Myra , Dueck, Amylou C. , Allred, Jacob B. ... - - Oncologist - 2019 Manuscript - Primary - Primary - Older Adult - A151411 , CALGB-40101 , CALGB-70301
Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance) Chhibber, Aparna , Mefford, Joel , Stahl, Eli A. ... - - Pharmacogenomics J. - 2014 Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101
Meta-analysis identifies variants in S1PR1 associated with microtubule targeting agent-induced sensory peripheral neuropathy CALGB 40101 and 40502 (Alliance) Chua, Katherina C. , Ho, Carol , Mushiroda, Tasei , Jiang, Chen ... - ASCPT - Clinical Pharmacology & Therapeutics - 2018 Abstract - Secondary-not-in-original - Meta-Analysis - Breast - CALGB-40101 , CALGB-40502
Genome-Wide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy Chua, Katherina C. , Xiong, Chenling , Ho, Carol , Mushiroda, Taisei ... - - Clin Pharmacol Ther - 2020 Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40101 , CALGB-40502
Is there a role for older-patient-specific trials? a pooled analysis of 2277 older patients in adjuvant breast cancer trials (Alliance A151715) Dao, Dyda , Zelma, Tyler , Jatoi, Aminah , Freedman, Rachel ... - ASCO - J Clin Oncol - 2018 Abstract - Primary - Primary - Older Adult - C8541 , A151715 , CALGB-40101 , CALGB-49907 , CALGB-9344 , CALGB-9741 , N89-30-52 , N9831
Participation in cancer pharmacogenomic studies in 8,456 patients registered to Cancer and Leukemia Group B (Alliance) clinical trials Dressler, L. G. , Deal, A. M. , Watson, D. , Hollis, D. , Owzar, K. ... - - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original - Meta-Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401
Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance) Dressler, Lynn G. , Deal, Allison M. , Owzar, Kouros ... - - J. Natl. Cancer Inst - 2015 Manuscript - Secondary-not-in-original - Meta-Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80101 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401
Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527 Freedman, Rachel A. , Foster, Jared C. , Seisler, Drew K. ... - - J. Clin. Oncol - 2017 Manuscript - Primary - Primary - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511) Freedman, Rachel A. , Seisler, D. K. , Foster, J. C. , Sloan, J. A. ... - - Breast Cancer Res. Treat. - 2017 Manuscript - Primary - Primary - Older Adult - A151511 , CALGB-40101 , CALGB-49907 , CALGB-9344 , CALGB-9741
Accrual of Older Breast Cancer Patients to Alliance Systemic Therapy Protocols over Time: Alliance A151527 Freedman, Rachel A , Seisler, Drew K. , Foster, Jared C. ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Primary - Primary - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831
Inherited genetic variation in EPHA5, FGD4 and NRDG1 and paclitaxel (P) induced peripheral neuropathy (PN): Results from a genome-wide association study (GWAS) in CALGB 40101 Kroetz, D. L. , Baldwin, R. , Owzar, K. , Jiang, C. , Zembutsu, H. ... - - J. Clin. Oncol. - 2010 Abstract - Primary - Primary - PPP - C60202 , CALGB-40101
Six cycles of Doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: cancer and leukemia group B 40101 Shulman, L. N. , Cirrincione, C. T. , Berry, D. A. , Becker, H. P. ... - - J. Clin. Oncol. - 2012 Manuscript - Primary - Primary - Breast - CALGB-40101
Four vs 6 Cycles of Doxorubicin and Cyclophosphamide (AC) or Paclitaxel (T) as Adjuvant Therapy for Breast Cancer in Women with 0-3 Positive Axillary Nodes: CALGB 40101 A 2x2 Factorial Phase III Trial: First Results Comparing 4 vs 6 Cycles of Therapy. Shulman, L. N. , Cirrincione, C. T. , Berry, D. A. , Becker, H. P. ... - SABCS - - 2010 Abstract - Primary - Preliminary - Breast - CALGB-40101
Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB 40101 (Alliance) Shulman, Lawrence N. , Berry, Donald A. , Cirrincione, Constance T. ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - Breast - CALGB-40101
Genome-Wide Meta-Analyses Identifies Novel Taxane-Induced Peripheral Neuropathy Associated Loci Sucheston-Campbell, L E , Clay-Gilmour, A I , Barlow, W E , Budd, G T ... - - Pharmacogenet. Genomics - 2018 Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40101 , S0221
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of paclitaxel-induced sensory peripheral neuropathy Wheeler, Heather E. , Gamazon, Eric R. , Wing, Claudia ... - - Clin. Cancer Res. - 2013 Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101